VEGFA and non-small cell lung carcinoma: VEGF expression is a marker of poor prognosis in NSCLC (Kaya et al, 2004); as such, VEGF‐targeted therapies are widely used to target VEGF‐mediated angiogenesis, although the details of how they exert their effects are not yet clearly defined (Ellis & Hicklin, 2008).